» Articles » PMID: 2023216

IgG Autoantibodies Against C1q Are Correlated with Nephritis, Hypocomplementemia, and DsDNA Antibodies in Systemic Lupus Erythematosus

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 1991 Feb 1
PMID 2023216
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the association between serum titers of IgG antibodies against C1q (C1qAb) and clinical and laboratory variables of disease activity in systemic lupus erythematosus (SLE). C1qAb were measured by ELISA in serum samples of 88 patients. Thirty patients (34%) had increased C1qAb titers. No correlation between C1qAb titers and a score for general disease activity was found. However, significant positive correlations were found between C1qAb titers and the presence of several clinical and laboratory variables of disease activity. These included nephritis, dermatitis, hypocomplementemia, antibodies against dsDNA, and circulating immune complexes. A negative correlation was found with neurological disease manifestations. The correlations between C1qAb titers and clinical features indicate that the pathogenetic role for C1qAb in certain disease manifestations of SLE deserves further study.

Citing Articles

Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review.

Calatroni M, Moroni G, Conte E, Stella M, Reggiani F, Ponticelli C Front Immunol. 2024; 15:1410032.

PMID: 38938561 PMC: 11208682. DOI: 10.3389/fimmu.2024.1410032.


Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus.

Yamato M, Shirai T, Ishii Y, Sato H, Ishii T, Fujii H Clin Rheumatol. 2024; 43(3):1023-1035.

PMID: 38334937 DOI: 10.1007/s10067-024-06904-9.


Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.

Radanova M, Vasilev V, Mihaylova G, Kosturkova M, Kishore U, Roumenina L Int J Mol Sci. 2022; 23(16).

PMID: 36012546 PMC: 9409282. DOI: 10.3390/ijms23169281.


Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40-CD154-mediated inflammation in peripheral blood mononuclear cells .

Rabatscher P, Trendelenburg M Clin Transl Immunology. 2022; 11(8):e1408.

PMID: 35928801 PMC: 9345742. DOI: 10.1002/cti2.1408.


Understanding the contextual functions of C1q and LAIR-1 and their applications.

Son M Exp Mol Med. 2022; 54(5):567-572.

PMID: 35562585 PMC: 9098383. DOI: 10.1038/s12276-022-00774-4.